SBH Sciences, a preclinical contract research organization well known for its cytokine assays and protein production, is pleased to announce the expansion of its research services to cover the drug discovery spectrum from in-vitro lead optimization through innovative animal modeling and companion diagnostics. SBH Sciences has over 180 human cancer cell lines, 280 bioassays, 31 recombinant cytokines, 8 recombinant Glycosyltransferase enzymes, 33 monoclonal antibodies, development of 30 ELISA kits and Multiplex analyses. SBH is the world leader in cell-based assay to measure biological activity of cytokines and has provided services to over 100 biotechnology companies across the globe in our 15 years of business.